Revati Kasture, Head of Research, CARE Ratings says with stricter operational and maintenance norms coming into play and tax benefits slated to be passed on to the consumer, NTPC would see a deceleration in its RoE. Money Control, 1 day ago
1 images for "revati kasture"
The market size of the segment is expected to be about $7.3 billion (Rs 45,300 crore) for 2013, according to Revati Kasture, head of CARE Research. HYDERABAD: Pharmaceutical companies that carry out contract manufacturing and research are in for tough times ...Economic Times, 2 weeks ago
The Reserve Bank of India (RBI) on Tuesday decided to consider incremental bank loans to medium manufacturing enterprises (as defined in the Micro, Small and Medium Enterprises Development Act, 2006), extended after November 13, as priority sector ...Business Standard India, 2 weeks ago
Drugmakers say costs for raw materials from China are exploding as rupee implodes Share Tools Pharma likes India for manufacturing because of its low costs. But costs are relative, and domestic contract manufacturers there are having a hard go ...FiercePharmaManufacturing, 2 weeks ago
HYDERABAD: Pharmaceutical companies that carry out contract manufacturing and research are in for tough times because of a fluctuating rupee, rising raw material costs and the looming expiry of tax incentives. Most of these companies have ...Economic Times, 2 weeks ago Pharma: Re swing, cost rise make for a bad concoction Economic Times, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!